These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 17396000)

  • 21. Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite.
    Nancollas GH; Tang R; Phipps RJ; Henneman Z; Gulde S; Wu W; Mangood A; Russell RG; Ebetino FH
    Bone; 2006 May; 38(5):617-27. PubMed ID: 16046206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [New therapy using bisphosphonate for urolithiasis].
    Yasui T; Niimi K; Hirose M
    Clin Calcium; 2011 Oct; 21(10):1511-5. PubMed ID: 21960237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uncovering the cause of "phossy jaw" Circa 1858 to 1906: oral and maxillofacial surgery closed case files-case closed.
    Marx RE
    J Oral Maxillofac Surg; 2008 Nov; 66(11):2356-63. PubMed ID: 18940506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bisphosphonates: effects on osteoblast.
    Maruotti N; Corrado A; Neve A; Cantatore FP
    Eur J Clin Pharmacol; 2012 Jul; 68(7):1013-8. PubMed ID: 22318756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The chemistry of bisphosphonates: from antiscaling agents to clinical therapeutics.
    Widler L; Jahnke W; Green JR
    Anticancer Agents Med Chem; 2012 Feb; 12(2):95-101. PubMed ID: 21864230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alternative indications for bisphosphonate therapy.
    Landesberg R; Eisig S; Fennoy I; Siris E
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):27-34. PubMed ID: 19371812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bisphosphonates: mode of action and pharmacology.
    Russell RG
    Pediatrics; 2007 Mar; 119 Suppl 2():S150-62. PubMed ID: 17332236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bisphosphonates and osteonecrosis of the jaws: science and rationale.
    Gutta R; Louis PJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Aug; 104(2):186-93. PubMed ID: 17448709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological diversity among drugs that inhibit bone resorption.
    Russell RG
    Curr Opin Pharmacol; 2015 Jun; 22():115-30. PubMed ID: 26048735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg.
    Abelson A
    Curr Med Res Opin; 2008 Mar; 24(3):695-705. PubMed ID: 18226324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bisphosphonates and the treatment of bone disease in the elderly.
    Johansen A; Stone M; Rawlinson F
    Drugs Aging; 1996 Feb; 8(2):113-26. PubMed ID: 8845585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Image assessment of the treatment effect on osteoporosis: bisphosphonates].
    Sone T
    Clin Calcium; 2011 Jul; 21(7):1041-6. PubMed ID: 21719985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The incidence and management of bone metastasis from breast cancer].
    Saeki T; Ookubo K; Takeuchi H; Fujiuchi N
    Gan To Kagaku Ryoho; 2006 Aug; 33(8):1054-7. PubMed ID: 16912520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Development of bisphosphonates].
    Nakatsuka K
    Nihon Rinsho; 2003 Feb; 61(2):219-25. PubMed ID: 12638211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complication related to bisphosphonate therapy: osteonecrosis of the jaw.
    Lee J
    J Infus Nurs; 2009; 32(6):330-5. PubMed ID: 19918142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bisphosphonate therapy for women with breast cancer and at high risk for osteoporosis.
    Morris GJ; Mitchell EP
    J Natl Med Assoc; 2007 Jan; 99(1):35-45. PubMed ID: 17304967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bisphosphonates and osteonecrosis: potential treatment or serious complication?
    Goytia RN; Salama A; Khanuja HS
    Orthop Clin North Am; 2009 Apr; 40(2):223-34. PubMed ID: 19358907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of bisphosphonate treatment in clinical practice.
    Aapro MS
    Semin Oncol; 2007 Dec; 34(6 Suppl 4):S28-32. PubMed ID: 18068488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bisphosphonates for osteoporosis.
    Favus MJ
    N Engl J Med; 2010 Nov; 363(21):2027-35. PubMed ID: 21083387
    [No Abstract]   [Full Text] [Related]  

  • 40. Bone-specific drug delivery systems: approaches via chemical modification of bone-seeking agents.
    Hirabayashi H; Fujisaki J
    Clin Pharmacokinet; 2003; 42(15):1319-30. PubMed ID: 14674786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.